Abdel-Haq R.

Schlachetzki J.C.M.

Glass C.K.

Mazmanian S.K. Microbiome-microglia connections via the gut-brain axis. J. Exp. Med. 216 : 41-59 View in Article Google Scholar

ADAPT-FS Research Group Follow-up evaluation of cognitive function in the randomized Alzheimer’s Disease Anti-inflammatory Prevention Trial and its Follow-up Study. Alzheimers Dement. 11 : 216-225.e1 View in Article Google Scholar

Ahmed Z.

Cooper J.

Murray T.K.

Garn K.

McNaughton E.

Clarke H.

Parhizkar S.

Ward M.A.

Cavallini A.

Jackson S.

et al. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity. Acta Neuropathol. 127 : 667-683 View in Article Google Scholar

Aisen P.S.

Davis K.L.

Berg J.D.

Schafer K.

Campbell K.

Thomas R.G.

Weiner M.F.

Farlow M.R.

Sano M.

Grundman M.

Thal L.J. A randomized controlled trial of prednisone in Alzheimer’s disease. Alzheimer’s Disease Cooperative Study. Neurology. 54 : 588-593 View in Article Google Scholar

Aisen P.S.

Schafer K.A.

Grundman M.

Pfeiffer E.

Sano M.

Davis K.L.

Farlow M.R.

Jin S.

Thomas R.G.

Thal L.J.

Alzheimer’s Disease Cooperative Study Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 289 : 2819-2826 View in Article Google Scholar

Altmann A.

Ng B.

Landau S.M.

Jagust W.J.

Greicius M.D.

Alzheimer’s Disease Neuroimaging Initiative Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain. 138 : 3734-3746 View in Article Google Scholar

Alzheimer’s Association 2019 Alzheimer’s disease facts and figures. Alzheimers Dement. 15 : 321-387 View in Article Google Scholar

Asai H.

Ikezu S.

Tsunoda S.

Medalla M.

Luebke J.

Haydar T.

Wolozin B.

Butovsky O.

Kügler S.

Ikezu T. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat. Neurosci. 18 : 1584-1593 View in Article Google Scholar

Aschenbrenner A.J.

Gordon B.A.

Benzinger T.L.S.

Morris J.C.

Hassenstab J.J. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. 91 : e859-e866 View in Article Google Scholar

Atri A.

Frölich L.

Ballard C.

Tariot P.N.

Molinuevo J.L.

Boneva N.

Windfeld K.

Raket L.L.

Cummings J.L. Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials. JAMA. 319 : 130-142 View in Article Google Scholar

Bales K.R.

Verina T.

Dodel R.C.

Du Y.

Altstiel L.

Bender M.

Hyslop P.

Johnstone E.M.

Little S.P.

Cummins D.J.

et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. 17 : 263-264 View in Article Google Scholar

Bales K.R.

Verina T.

Cummins D.J.

Du Y.

Dodel R.C.

Saura J.

Fishman C.E.

DeLong C.A.

Piccardo P.

Petegnief V.

et al. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA. 96 : 15233-15238 View in Article Google Scholar

Bales K.R.

Liu F.

Wu S.

Lin S.

Koger D.

DeLong C.

Hansen J.C.

Sullivan P.M.

Paul S.M. Human APOE isoform-dependent effects on brain beta-amyloid levels in PDAPP transgenic mice. J. Neurosci. 29 : 6771-6779 View in Article Google Scholar

Bartus R.T.

Dean 3rd, R.L.

Beer B.

Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217 : 408-414 View in Article Google Scholar

Basak J.M.

Verghese P.B.

Yoon H.

Kim J.

Holtzman D.M. Low-density lipoprotein receptor represents an apolipoprotein E-independent pathway of Aβ uptake and degradation by astrocytes. J. Biol. Chem. 287 : 13959-13971 View in Article Google Scholar

Bateman R.J.

Xiong C.

Benzinger T.L.S.

Fagan A.M.

Goate A.

Fox N.C.

Marcus D.S.

Cairns N.J.

Xie X.

Blazey T.M.

et al.

Dominantly Inherited Alzheimer Network Clinical and biomarker changes in dominantly inherited Alzheimer’s disease. N. Engl. J. Med. 367 : 795-804 View in Article Google Scholar

Bateman R.J.

Benzinger T.L.

Berry S.

Clifford D.B.

Duggan C.

Fagan A.M.

Fanning K.

Farlow M.R.

Hassenstab J.

McDade E.M.

et al.

DIAN-TU Pharma Consortium for the Dominantly Inherited Alzheimer Network The DIAN-TU Next Generation Alzheimer’s prevention trial: Adaptive design and disease progression model. Alzheimers Dement. 13 : 8-19 View in Article Google Scholar

Bäuerl C.

Collado M.C.

Diaz Cuevas A.

Viña J.

Pérez Martínez G. Shifts in gut microbiota composition in an APP/PSS1 transgenic mouse model of Alzheimer’s disease during lifespan. Lett. Appl. Microbiol. 66 : 464-471 View in Article Google Scholar

Bell R.D.

Winkler E.A.

Singh I.

Sagare A.P.

Deane R.

Wu Z.

Holtzman D.M.

Betsholtz C.

Armulik A.

Sallstrom J.

et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 485 : 512-516 View in Article Google Scholar

Bentham P.

Gray R.

Sellwood E.

Hills R.

Crome P.

Raftery J.

AD2000 Collaborative Group Aspirin in Alzheimer’s disease (AD2000): a randomised open-label trial. Lancet Neurol. 7 : 41-49 View in Article Google Scholar

Bero A.W.

Yan P.

Roh J.H.

Cirrito J.R.

Stewart F.R.

Raichle M.E.

Lee J.-M.

Holtzman D.M. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat. Neurosci. 14 : 750-756 View in Article Google Scholar

Bien-Ly N.

Gillespie A.K.

Walker D.

Yoon S.Y.

Huang Y. Reducing human apolipoprotein E levels attenuates age-dependent Aβ accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32 : 4803-4811 View in Article Google Scholar

Biere A.L.

Ostaszewski B.

Zhao H.

Gillespie S.

Younkin S.G.

Selkoe D.J. Co-expression of beta-amyloid precursor protein (betaAPP) and apolipoprotein E in cell culture: analysis of betaAPP processing. Neurobiol. Dis. 2 : 177-187 View in Article Google Scholar

Biernat J.

Gustke N.

Drewes G.

Mandelkow E.M.

Mandelkow E. Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron. 11 : 153-163 View in Article Google Scholar

Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst. Rev. : CD005593 View in Article Google Scholar

Boada M.

López O.

Núñez L.

Szczepiorkowski Z.M.

Torres M.

Grifols C.

Páez A. Plasma exchange for Alzheimer’s disease Management by Albumin Replacement (AMBAR) trial: Study design and progress. Alzheimers Dement. (N. Y.). 5 : 61-69 View in Article Google Scholar

Bolmont T.

Clavaguera F.

Meyer-Luehmann M.

Herzig M.C.

Radde R.

Staufenbiel M.

Lewis J.

Hutton M.

Tolnay M.

Jucker M. Induction of tau pathology by intracerebral infusion of amyloid-beta -containing brain extract and by amyloid-beta deposition in APP x Tau transgenic mice. Am. J. Pathol. 171 : 2012-2020 View in Article Google Scholar

Bourgade K.

Garneau H.

Giroux G.

Le Page A.Y.

Bocti C.

Dupuis G.

Frost E.H.

Fülöp Jr., T. β-Amyloid peptides display protective activity against the human Alzheimer’s disease-associated herpes simplex virus-1. Biogerontology. 16 : 85-98 View in Article Google Scholar

Boxer A.L.

Qureshi I.

Ahlijanian M.

Grundman M.

Golbe L.I.

Litvan I.

Honig L.S.

Tuite P.

McFarland N.R.

O’Suilleabhain P.

et al. Safety of the tau-directed monoclonal antibody BIIB092 in progressive supranuclear palsy: a randomised, placebo-controlled, multiple ascending dose phase 1b trial. Lancet Neurol. 18 : 549-558 View in Article Google Scholar

Braak H.

Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82 : 239-259 View in Article Google Scholar

Bradshaw E.M.

Chibnik L.B.

Keenan B.T.

Ottoboni L.

Raj T.

Tang A.

Rosenkrantz L.L.

Imboywa S.

Lee M.

Von Korff A.

et al.

Alzheimer Disease Neuroimaging Initiative CD33 Alzheimer’s disease locus: altered monocyte function and amyloid biology. Nat. Neurosci. 16 : 848-850 View in Article Google Scholar

Bridel C.

van Wieringen W.N.

Zetterberg H.

Tijms B.M.

Teunissen C.E.

Alvarez-Cermeño J.C.

Andreasson U.

Axelsson M.

Bäckström D.C.

Bartos A.

et al.

and the NFL Group Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis. JAMA Neurol. ( ) https://doi.org/10.1001/jamaneurol.2019.1534 View in Article Google Scholar

Brier M.R.

Day G.S.

Snyder A.Z.

Tanenbaum A.B.

Ances B.M. N-methyl-D-aspartate receptor encephalitis mediates loss of intrinsic activity measured by functional MRI. J. Neurol. 263 : 1083-1091 View in Article Google Scholar

Brody D.L.

Magnoni S.

Schwetye K.E.

Spinner M.L.

Esparza T.J.

Stocchetti N.

Zipfel G.J.

Holtzman D.M. Amyloid-beta dynamics correlate with neurological status in the injured human brain. Science. 321 : 1221-1224 View in Article Google Scholar

Burke W.J.

Miller J.P.

Rubin E.H.

Morris J.C.

Coben L.A.

Duchek J.

Wittels I.G.

Berg L. Reliability of the Washington University Clinical Dementia Rating. Arch. Neurol. 45 : 31-32 View in Article Google Scholar

Bussy A.

Snider B.J.

Coble D.

Xiong C.

Fagan A.M.

Cruchaga C.

Benzinger T.L.S.

Gordon B.A.

Hassenstab J.

Bateman R.J.

Morris J.C.

Dominantly Inherited Alzheimer Network Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiol. Aging. 75 : 42-50 View in Article Google Scholar

Butchart J.

Brook L.

Hopkins V.

Teeling J.

Püntener U.

Culliford D.

Sharples R.

Sharif S.

McFarlane B.

Raybould R.

et al. Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trial. Neurology. 84 : 2161-2168 View in Article Google Scholar

Buttini M.

Orth M.

Bellosta S.

Akeefe H.

Pitas R.E.

Wyss-Coray T.

Mucke L.

Mahley R.W. Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J. Neurosci. 19 : 4867-4880 View in Article Google Scholar

Buttini M.

Masliah E.

Yu G.-Q.

Palop J.J.

Chang S.

Bernardo A.

Lin C.

Wyss-Coray T.

Huang Y.

Mucke L. Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice. Am. J. Pathol. 177 : 563-569 View in Article Google Scholar

Cano-Cuenca N.

Solís-García del Pozo J.E.

Jordán J. Evidence for the efficacy of latrepirdine (Dimebon) treatment for improvement of cognitive function: a meta-analysis. J. Alzheimers Dis. 38 : 155-164 View in Article Google Scholar

Carbone I.

Lazzarotto T.

Ianni M.

Porcellini E.

Forti P.

Masliah E.

Gabrielli L.

Licastro F. Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol. Aging. 35 : 122-129 View in Article Google Scholar

Carlsson C.M.

Gleason C.E.

Hess T.M.

Moreland K.A.

Blazel H.M.

Koscik R.L.

Schreiber N.T.N.

Johnson S.C.

Atwood C.S.

Puglielli L.

et al. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer’s disease. J. Alzheimers Dis. 13 : 187-197 View in Article Google Scholar

Castellano J.M.

Kim J.

Stewart F.R.

Jiang H.

DeMattos R.B.

Patterson B.W.

Fagan A.M.

Morris J.C.

Mawuenyega K.G.

Cruchaga C.

et al. Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci. Transl. Med. 3 : 89ra57 View in Article Google Scholar

Castellano J.M.

Deane R.

Gottesdiener A.J.

Verghese P.B.

Stewart F.R.

West T.

Paoletti A.C.

Kasper T.R.

DeMattos R.B.

Zlokovic B.V.

Holtzman D.M. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood Aβ clearance in a mouse model of β-amyloidosis. Proc. Natl. Acad. Sci. USA. 109 : 15502-15507 View in Article Google Scholar

Castellano J.M.

Mosher K.I.

Abbey R.J.

McBride A.A.

James M.L.

Berdnik D.

Shen J.C.

Zou B.

Xie X.S.

Tingle M.

et al. Human umbilical cord plasma proteins revitalize hippocampal function in aged mice. Nature. 544 : 488-492 View in Article Google Scholar

Cedazo-Mínguez A.

Wiehager B.

Winblad B.

Hüttinger M.

Cowburn R.F. Effects of apolipoprotein E (apoE) isoforms, beta-amyloid (Abeta) and apoE/Abeta complexes on protein kinase C-alpha (PKC-alpha) translocation and amyloid precursor protein (APP) processing in human SH-SY5Y neuroblastoma cells and fibroblasts. Neurochem. Int. 38 : 615-625 View in Article Google Scholar

Chang R.

Knox J.

Chang J.

Derbedrossian A.

Vasilevko V.

Cribbs D.

Boado R.J.

Pardridge W.M.

Sumbria R.K. Blood-Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease. Mol. Pharm. 14 : 2340-2349 View in Article Google Scholar

Chen V.C.-H.

Wu S.-I.

Huang K.-Y.

Yang Y.-H.

Kuo T.-Y.

Liang H.-Y.

Huang K.-L.

Gossop M. Herpes Zoster and Dementia: A Nationwide Population-Based Cohort Study. J. Clin. Psychiatry. 79 : 16m11312 View in Article Google Scholar

Choi S.H.

Kim Y.H.

Hebisch M.

Sliwinski C.

Lee S.

D’Avanzo C.

Chen H.

Hooli B.

Asselin C.

Muffat J.

et al. A three-dimensional human neural cell culture model of Alzheimer’s disease. Nature. 515 : 274-278 View in Article Google Scholar

Chou R.C.

Kane M.

Ghimire S.

Gautam S.

Gui J. Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis. CNS Drugs. 30 : 1111-1120 View in Article Google Scholar

Cirrito J.R.

Yamada K.A.

Finn M.B.

Sloviter R.S.

Bales K.R.

May P.C.

Schoepp D.D.

Paul S.M.

Mennerick S.

Holtzman D.M. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 48 : 913-922 View in Article Google Scholar

Cirrito J.R.

Kang J.-E.

Lee J.

Stewart F.R.

Verges D.K.

Silverio L.M.

Bu G.

Mennerick S.

Holtzman D.M. Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron. 58 : 42-51 View in Article Google Scholar

Clavaguera F.

Bolmont T.

Crowther R.A.

Abramowski D.

Frank S.

Probst A.

Fraser G.

Stalder A.K.

Beibel M.

Staufenbiel M.

et al. Transmission and spreading of tauopathy in transgenic mouse brain. Nat. Cell Biol. 11 : 909-913 View in Article Google Scholar

Clavaguera F.

Akatsu H.

Fraser G.

Crowther R.A.

Frank S.

Hench J.

Probst A.

Winkler D.T.

Reichwald J.

Staufenbiel M.

et al. Brain homogenates from human tauopathies induce tau inclusions in mouse brain. Proc. Natl. Acad. Sci. USA. 110 : 9535-9540 View in Article Google Scholar

Colonna M.

Butovsky O. Microglia Function in the Central Nervous System During Health and Neurodegeneration. Annu. Rev. Immunol. 35 : 441-468 View in Article Google Scholar

Commissioner, O. of the (2019). Statement from FDA Commissioner Scott Gottlieb, M.D., and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, M.D., Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions. View in Article Google Scholar

Congdon E.E.

Wu J.W.

Myeku N.

Figueroa Y.H.

Herman M.

Marinec P.S.

Gestwicki J.E.

Dickey C.A.

Yu W.H.

Duff K.E. Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy. 8 : 609-622 View in Article Google Scholar

Cook C.

Carlomagno Y.

Gendron T.F.

Dunmore J.

Scheffel K.

Stetler C.

Davis M.

Dickson D.

Jarpe M.

DeTure M.

Petrucelli L. Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance. Hum. Mol. Genet. 23 : 104-116 View in Article Google Scholar

Corder E.H.

Saunders A.M.

Strittmatter W.J.

Schmechel D.E.

Gaskell P.C.

Small G.W.

Roses A.D.

Haines J.L.

Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science. 261 : 921-923 View in Article Google Scholar

Coric V.

Salloway S.

van Dyck C.H.

Dubois B.

Andreasen N.

Brody M.

Curtis C.

Soininen H.

Thein S.

Shiovitz T.

et al. Targeting Prodromal Alzheimer Disease With Avagacestat: A Randomized Clinical Trial. JAMA Neurol. 72 : 1324-1333 View in Article Google Scholar

Crary J.F.

Trojanowski J.Q.

Schneider J.A.

Abisambra J.F.

Abner E.L.

Alafuzoff I.

Arnold S.E.

Attems J.

Beach T.G.

Bigio E.H.

et al. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 128 : 755-766 View in Article Google Scholar

Crowe A.

James M.J.

Lee V.M.-Y.

Smith 3rd, A.B.

Trojanowski J.Q.

Ballatore C.

Brunden K.R. Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation. J. Biol. Chem. 288 : 11024-11037 View in Article Google Scholar

Crowther R.A.

Wischik C.M. Image reconstruction of the Alzheimer paired helical filament. EMBO J. 4 : 3661-3665 View in Article Google Scholar

Cruz Hernández J.C.

Bracko O.

Kersbergen C.J.

Muse V.

Haft-Javaherian M.

Berg M.

Park L.

Vinarcsik L.K.

Ivasyk I.

Rivera D.A.

et al. Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer’s disease mouse models. Nat. Neurosci. 22 : 413-420 View in Article Google Scholar

Da Mesquita S.

Louveau A.

Vaccari A.

Smirnov I.

Cornelison R.C.

Kingsmore K.M.

Contarino C.

Onengut-Gumuscu S.

Farber E.

Raper D.

et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease. Nature. 560 : 185-191 View in Article Google Scholar

Dawson H.N.

Ferreira A.

Eyster M.V.

Ghoshal N.

Binder L.I.

Vitek M.P. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell Sci. 114 : 1179-1187 View in Article Google Scholar

de Calignon A.

Polydoro M.

Suárez-Calvet M.

William C.

Adamowicz D.H.

Kopeikina K.J.

Pitstick R.

Sahara N.

Ashe K.H.

Carlson G.A.

et al. Propagation of tau pathology in a model of early Alzheimer’s disease. Neuron. 73 : 685-697 View in Article Google Scholar

de Jong D.

Jansen R.

Hoefnagels W.

Jellesma-Eggenkamp M.

Verbeek M.

Borm G.

Kremer B. No effect of one-year treatment with indomethacin on Alzheimer’s disease progression: a randomized controlled trial. PLoS ONE. 3 : e1475 View in Article Google Scholar

De Strooper B. Lessons from a failed γ-secretase Alzheimer trial. Cell. 159 : 721-726 View in Article Google Scholar

De Strooper B.

Karran E. The Cellular Phase of Alzheimer’s Disease. Cell. 164 : 603-615 View in Article Google Scholar

DeMattos R.B.

Bales K.R.

Cummins D.J.

Dodart J.C.

Paul S.M.

Holtzman D.M. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer’s disease. Proc. Natl. Acad. Sci. USA. 98 : 8850-8855 View in Article Google Scholar

DeVos S.L.

Miller R.L.

Schoch K.M.

Holmes B.B.

Kebodeaux C.S.

Wegener A.J.

Chen G.

Shen T.

Tran H.

Nichols B.

et al. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy. Sci. Transl. Med. 9 : eaag0481 View in Article Google Scholar

DeVos S.L.

Corjuc B.T.

Oakley D.H.

Nobuhara C.K.

Bannon R.N.

Chase A.

Commins C.

Gonzalez J.A.

Dooley P.M.

Frosch M.P.

Hyman B.T. Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer’s Disease Brain. Front. Neurosci. 12 : 267 View in Article Google Scholar

Dixit R.

Ross J.L.

Goldman Y.E.

Holzbaur E.L.F. Differential regulation of dynein and kinesin motor proteins by tau. Science. 319 : 1086-1089 View in Article Google Scholar

Dominy S.S.

Lynch C.

Ermini F.

Benedyk M.

Marczyk A.

Konradi A.

Nguyen M.

Haditsch U.

Raha D.

Griffin C.

et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small-molecule inhibitors. Sci Adv. 5 : eaau3333 View in Article Google Scholar

Doody R.S.

Raman R.

Farlow M.

Iwatsubo T.

Vellas B.

Joffe S.

Kieburtz K.

He F.

Sun X.

Thomas R.G.

et al.

Alzheimer’s Disease Cooperative Study Steering Committee

Semagacestat Study Group A phase 3 trial of semagacestat for treatment of Alzheimer’s disease. N. Engl. J. Med. 369 : 341-350 View in Article Google Scholar

Doody R.S.

Thomas R.G.

Farlow M.

Iwatsubo T.

Vellas B.

Joffe S.

Kieburtz K.

Raman R.

Sun X.

Aisen P.S.

et al.

Alzheimer’s Disease Cooperative Study Steering Committee

Solanezumab Study Group Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N. Engl. J. Med. 370 : 311-321 View in Article Google Scholar

Dumanis S.B.

Tesoriero J.A.

Babus L.W.

Nguyen M.T.

Trotter J.H.

Ladu M.J.

Weeber E.J.

Turner R.S.

Xu B.

Rebeck G.W.

Hoe H.S. ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo. J. Neurosci. 29 : 15317-15322 View in Article Google Scholar

Duyckaerts C.

Delatour B.

Potier M.-C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118 : 5-36 View in Article Google Scholar

Edison P.

Archer H.A.

Hinz R.

Hammers A.

Pavese N.

Tai Y.F.

Hotton G.

Cutler D.

Fox N.

Kennedy A.

et al. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 68 : 501-508 View in Article Google Scholar

Efthymiou A.G.

Goate A.M. Late onset Alzheimer’s disease genetics implicates microglial pathways in disease risk. Mol. Neurodegener. 12 : 43 View in Article Google Scholar

Egan M.F.

Kost J.

Tariot P.N.

Aisen P.S.

Cummings J.L.

Vellas B.

Sur C.

Mukai Y.

Voss T.

Furtek C.

et al. Randomized Trial of Verubecestat for Mild-to-Moderate Alzheimer’s Disease. N. Engl. J. Med. 378 : 1691-1703 View in Article Google Scholar

Egan M.F.

Kost J.

Voss T.

Mukai Y.

Aisen P.S.

Cummings J.L.

Tariot P.N.

Vellas B.

van Dyck C.H.

Boada M.

et al. Randomized Trial of Verubecestat for Prodromal Alzheimer’s Disease. N. Engl. J. Med. 380 : 1408-1420 View in Article Google Scholar

Eimer W.A.

Vijaya Kumar D.K.

Navalpur Shanmugam N.K.

Rodriguez A.S.

Mitchell T.

Washicosky K.J.

György B.

Breakefield X.O.

Tanzi R.E.

Moir R.D. Alzheimer’s Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection. Neuron. 99 : 56-63.e3 View in Article Google Scholar

Eisele Y.S.

Bolmont T.

Heikenwalder M.

Langer F.

Jacobson L.H.

Yan Z.-X.

Roth K.

Aguzzi A.

Staufenbiel M.

Walker L.C.

Jucker M. Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation. Proc. Natl. Acad. Sci. USA. 106 : 12926-12931 View in Article Google Scholar

Eisele Y.S.

Obermüller U.

Heilbronner G.

Baumann F.

Kaeser S.A.

Wolburg H.

Walker L.C.

Staufenbiel M.

Heikenwalder M.

Jucker M. Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis. Science. 330 : 980-982 View in Article Google Scholar

Eriksen J.L.

Sagi S.A.

Smith T.E.

Weggen S.

Das P.

McLendon D.C.

Ozols V.V.

Jessing K.W.

Zavitz K.H.

Koo E.H.

Golde T.E. NSAIDs and enantiomers of flurbiprofen target gamma-secretase and lower Abeta 42 in vivo. J. Clin. Invest. 112 : 440-449 View in Article Google Scholar

Erny D.

Hrabě de Angelis A.L.

Jaitin D.

Wieghofer P.

Staszewski O.

David E.

Keren-Shaul H.

Mahlakoiv T.

Jakobshagen K.

Buch T.

et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18 : 965-977 View in Article Google Scholar

Ezzat K.

Pernemalm M.

Pålsson S.

Roberts T.C.

Järver P.

Dondalska A.

Bestas B.

Sobkowiak M.J.

Levänen B.

Sköld M.

et al. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat. Commun. 10 : 2331 View in Article Google Scholar

Fagan A.M.

Mintun M.A.

Mach R.H.

Lee S.-Y.

Dence C.S.

Shah A.R.

LaRossa G.N.

Spinner M.L.

Klunk W.E.

Mathis C.A.

et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans. Ann. Neurol. 59 : 512-519 View in Article Google Scholar

Fagan A.M.

Roe C.M.

Xiong C.

Mintun M.A.

Morris J.C.

Holtzman D.M. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch. Neurol. 64 : 343-349 View in Article Google Scholar

Fagan A.M.

Xiong C.

Jasielec M.S.

Bateman R.J.

Goate A.M.

Benzinger T.L.S.

Ghetti B.

Martins R.N.

Masters C.L.

Mayeux R.

et al.

Dominantly Inherited Alzheimer Network Longitudinal change in CSF biomarkers in autosomal-dominant Alzheimer’s disease. Sci. Transl. Med. 6 : 226ra30 View in Article Google Scholar

Feldman H.H.

Doody R.S.

Kivipelto M.

Sparks D.L.

Waters D.D.

Jones R.W.

Schwam E.

Schindler R.

Hey-Hadavi J.

DeMicco D.A.

Breazna A.

LEADe Investigators Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. Neurology. 74 : 956-964 View in Article Google Scholar

Felsky D.

Roostaei T.

Nho K.

Risacher S.L.

Bradshaw E.M.

Petyuk V.

Schneider J.A.

Saykin A.

Bennett D.A.

De Jager P.L. Neuropathological correlates and genetic architecture of microglial activation in elderly human brain. Nat. Commun. 10 : 409 View in Article Google Scholar

Finkel R.S.

Mercuri E.

Darras B.T.

Connolly A.M.

Kuntz N.L.

Kirschner J.

Chiriboga C.A.

Saito K.

Servais L.

Tizzano E.

et al.

ENDEAR Study Group Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy. N. Engl. J. Med. 377 : 1723-1732 View in Article Google Scholar

Fitzpatrick A.W.P.

Falcon B.

He S.

Murzin A.G.

Murshudov G.

Garringer H.J.

Crowther R.A.

Ghetti B.

Goedert M.

Scheres S.H.W. Cryo-EM structures of tau filaments from Alzheimer’s disease. Nature. 547 : 185-190 View in Article Google Scholar

Frost B.

Ollesch J.

Wille H.

Diamond M.I. Conformational diversity of wild-type Tau fibrils specified by templated conformation change. J. Biol. Chem. 284 : 3546-3551 View in Article Google Scholar

Gale S.C.

Gao L.

Mikacenic C.

Coyle S.M.

Rafaels N.

Murray Dudenkov T.

Madenspacher J.H.

Draper D.W.

Ge W.

Aloor J.J.

et al. APOε4 is associated with enhanced in vivo innate immune responses in human subjects. J. Allergy Clin. Immunol. 134 : 127-134 View in Article Google Scholar

Gallardo G.

Holtzman D.M. Antibody Therapeutics Targeting Aβ and Tau. Cold Spring Harb. Perspect. Med. 7 : a024331 View in Article Google Scholar

Gan K.J.

Südhof T.C. Specific factors in blood from young but not old mice directly promote synapse formation and NMDA-receptor recruitment. Proc. Natl. Acad. Sci. USA. 116 : 12524-12533 View in Article Google Scholar

Gauthier S.

Feldman H.H.

Schneider L.S.

Wilcock G.K.

Frisoni G.B.

Hardlund J.H.

Moebius H.J.

Bentham P.

Kook K.A.

Wischik D.J.

et al. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer’s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 388 : 2873-2884 View in Article Google Scholar

Gauthier S.

Alam J.

Fillit H.

Iwatsubo T.

Liu-Seifert H.

Sabbagh M.

Salloway S.

Sampaio C.

Sims J.R.

Sperling B.

et al. Combination Therapy for Alzheimer’s Disease: Perspectives of the EU/US CTAD Task Force. J. Prev. Alzheimers Dis. 6 : 164-168 View in Article Google Scholar

Giannakopoulos P.

Herrmann F.R.

Bussière T.

Bouras C.

Kövari E.

Perl D.P.

Morrison J.H.

Gold G.

Hof P.R. Tangle and neuron numbers, but not amyloid load, predict cognitive status in Alzheimer’s disease. Neurology. 60 : 1495-1500 View in Article Google Scholar

Glenner G.G.

Wong C.W. Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120 : 885-890 View in Article Google Scholar

Gómez-Isla T.

Price J.L.

McKeel Jr., D.W.

Morris J.C.

Growdon J.H.

Hyman B.T. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer’s disease. J. Neurosci. 16 : 4491-4500 View in Article Google Scholar

Gordon B.A.

Blazey T.

Su Y.

Fagan A.M.

Holtzman D.M.

Morris J.C.

Benzinger T.L.S. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. JAMA Neurol. 73 : 1192-1200 View in Article Google Scholar

Gordon B.A.

Blazey T.M.

Su Y.

Hari-Raj A.

Dincer A.

Flores S.

Christensen J.

McDade E.

Wang G.

Xiong C.

et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer’s disease: a longitudinal study. Lancet Neurol. 17 : 241-250 View in Article Google Scholar

Gorno-Tempini M.L.

Brambati S.M.

Ginex V.

Ogar J.

Dronkers N.F.

Marcone A.

Perani D.

Garibotto V.

Cappa S.F.

Miller B.L. The logopenic/phonological variant of primary progressive aphasia. Neurology. 71 : 1227-1234 View in Article Google Scholar

Götz J.

Chen F.

van Dorpe J.

Nitsch R.M. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science. 293 : 1491-1495 View in Article Google Scholar

Gratuze M.

Leyns C.E.G.

Holtzman D.M. New insights into the role of TREM2 in Alzheimer’s disease. Mol. Neurodegener. 13 : 66 View in Article Google Scholar

Green R.C.

Schneider L.S.

Amato D.A.

Beelen A.P.

Wilcock G.

Swabb E.A.

Zavitz K.H.

Tarenflurbil Phase 3 Study Group Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA. 302 : 2557-2564 View in Article Google Scholar

Greenamyre J.T.

Maragos W.F.

Albin R.L.

Penney J.B.

Young A.B. Glutamate transmission and toxicity in Alzheimer’s disease. Prog. Neuropsychopharmacol. Biol. Psychiatry. 12 : 421-430 View in Article Google Scholar

Gremer L.

Schölzel D.

Schenk C.

Reinartz E.

Labahn J.

Ravelli R.B.G.

Tusche M.

Lopez-Iglesias C.

Hoyer W.

Heise H.

et al. Fibril structure of amyloid-β(1-42) by cryo-electron microscopy. Science. 358 : 116-119 View in Article Google Scholar

Griciuc A.

Serrano-Pozo A.

Parrado A.R.

Lesinski A.N.

Asselin C.N.

Mullin K.

Hooli B.

Choi S.H.

Hyman B.T.

Tanzi R.E. Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 78 : 631-643 View in Article Google Scholar

Griciuc A.

Patel S.

Federico A.N.

Choi S.H.

Innes B.J.

Oram M.K.

Cereghetti G.

McGinty D.

Anselmo A.

Sadreyev R.I.

et al. TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease. Neuron. 103 : 820-835.e7 View in Article Google Scholar

Grimmer T.

Tholen S.

Yousefi B.H.

Alexopoulos P.

Förschler A.

Förstl H.

Henriksen G.

Klunk W.E.

Mathis C.A.

Perneczky R.

et al. Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer’s disease. Biol. Psychiatry. 68 : 879-884 View in Article Google Scholar

Guo J.L.

Narasimhan S.

Changolkar L.

He Z.

Stieber A.

Zhang B.

Gathagan R.J.

Iba M.

McBride J.D.

Trojanowski J.Q.

Lee V.M. Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice. J. Exp. Med. 213 : 2635-2654 View in Article Scopus (102)

Google Scholar

Guo T.

Noble W.

Hanger D.P. Roles of tau protein in health and disease. Acta Neuropathol. 133 : 665-704 View in Article Google Scholar

Haass C.

Kaether C.

Thinakaran G.

Sisodia S. Trafficking and proteolytic processing of APP. Cold Spring Harb. Perspect. Med. 2 : a006270 View in Article Google Scholar

Halle A.

Hornung V.

Petzold G.C.

Stewart C.R.

Monks B.G.

Reinheckel T.

Fitzgerald K.A.

Latz E.

Moore K.J.

Golenbock D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol. 9 : 857-865 View in Article Google Scholar

Han J.-Y.

Besser L.M.

Xiong C.

Kukull W.A.

Morris J.C. Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia. Alzheimer Dis. Assoc. Disord. 33 : 87-94 View in Article Google Scholar

Hanseeuw B.J.

Betensky R.A.

Jacobs H.I.L.

Schultz A.P.

Sepulcre J.

Becker J.A.

Cosio D.M.O.

Farrell M.

Quiroz Y.T.

Mormino E.C.

et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. JAMA Neurol. ( ) https://doi.org/10.1001/jamaneurol.2019.1424 View in Article Google Scholar

Hara Y.

McKeehan N.

Fillit H.M. Translating the biology of aging into novel therapeutics for Alzheimer disease. Neurology. 92 : 84-93 View in Article Google Scholar

Hardy J.A.

Higgins G.A. Alzheimer’s disease: the amyloid cascade hypothesis. Science. 256 : 184-185 View in Article Google Scholar

Harrington C.

Sawchak S.

Chiang C.

Davies J.

Donovan C.

Saunders A.M.

Irizarry M.

Jeter B.

Zvartau-Hind M.

van Dyck C.H.

Gold M. Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer’s disease: two phase 3 studies. Curr. Alzheimer Res. 8 : 592-606 View in Article Google Scholar

He Z.

Guo J.L.

McBride J.D.

Narasimhan S.

Kim H.

Changolkar L.

Zhang B.

Gathagan R.J.

Yue C.

Dengler C.

et al. Amyloid-β plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat. Med. 24 : 29-38 View in Article Google Scholar

Heckmann B.L.

Teubner B.J.W.

Tummers B.

Boada-Romero E.

Harris L.

Yang M.

Guy C.S.

Zakharenko S.S.

Green D.R. LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease. Cell. View in Article Google Scholar

Heneka M.T.

Kummer M.P.

Stutz A.

Delekate A.

Schwartz S.

Vieira-Saecker A.

Griep A.

Axt D.

Remus A.

Tzeng T.-C.

et al. NLRP3 is activated in Alzheimer’s disease and contributes to pathology in APP/PS1 mice. Nature. 493 : 674-678 View in Article Google Scholar

Henley D.

Raghavan N.

Sperling R.

Aisen P.

Raman R.

Romano G. Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer’s Disease. N. Engl. J. Med. 380 : 1483-1485 View in Article Google Scholar

Hitt B.D.

Jaramillo T.C.

Chetkovich D.M.

Vassar R. BACE1-/- mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol. Neurodegener. 5 : 31 View in Article Google Scholar

Holth, J.K., Fritschi, S.K., Wang, C., Pedersen, N.P., Cirrito, J.R., Mahan, T.E., Finn, M.B., Manis, M., Geerling, J.C., Fuller, P.M., et al. (2019). The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science eaav2546. View in Article Google Scholar

Holtzman D.M.

Pitas R.E.

Kilbridge J.

Nathan B.

Mahley R.W.

Bu G.

Schwartz A.L. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. Natl. Acad. Sci. USA. 92 : 9480-9484 View in Article Google Scholar

Hong S.

Beja-Glasser V.F.

Nfonoyim B.M.

Frouin A.

Li S.

Ramakrishnan S.

Merry K.M.

Shi Q.

Rosenthal A.

Barres B.A.

et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 352 : 712-716 View in Article Google Scholar

Honig L.S.

Vellas B.

Woodward M.

Boada M.

Bullock R.

Borrie M.

Hager K.

Andreasen N.

Scarpini E.

Liu-Seifert H.

et al. Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease. N. Engl. J. Med. 378 : 321-330 View in Article Google Scholar

Hoover B.R.

Reed M.N.

Su J.

Penrod R.D.

Kotilinek L.A.

Grant M.K.

Pitstick R.

Carlson G.A.

Lanier L.M.

Yuan L.-L.

et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron. 68 : 1067-1081 View in Article Google Scholar

Hu J.

Liu C.-C.

Chen X.-F.

Zhang Y.-W.

Xu H.

Bu G. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Mol. Neurodegener. 10 : 6 View in Article Google Scholar

Huang Y.A.

Zhou B.

Wernig M.

Südhof T.C. ApoE2, ApoE3, and ApoE4 Differentially Stimulate APP Transcription and Aβ Secretion. Cell. 168 : 427-441.e21 View in Article Google Scholar

Hudry E.

Dashkoff J.

Roe A.D.

Takeda S.

Koffie R.M.

Hashimoto T.

Scheel M.

Spires-Jones T.

Arbel-Ornath M.

Betensky R.

et al. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci. Transl. Med. 5 : 212ra161 View in Article Google Scholar

Hunter J.M.

Cirrito J.R.

Restivo J.L.

Kinley R.D.

Sullivan P.M.

Holtzman D.M.

Koger D.

Delong C.

Lin S.

Zhao L.

et al. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Res. 1467 : 120-132 View in Article Google Scholar

Hurtado D.E.

Molina-Porcel L.

Iba M.

Aboagye A.K.

Paul S.M.

Trojanowski J.Q.

Lee V.M.-Y. Abeta accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model. Am. J. Pathol. 177 : 1977-1988 View in Article Google Scholar

Huynh T.V.

Davis A.A.

Ulrich J.D.

Holtzman D.M. Apolipoprotein E and Alzheimer’s disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins. J. Lipid Res. 58 : 824-836 View in Article Google Scholar

Huynh T.V.

Liao F.

Francis C.M.

Robinson G.O.

Serrano J.R.

Jiang H.

Roh J.

Finn M.B.

Sullivan P.M.

Esparza T.J.

et al. Age-Dependent Effects of apoE Reduction Using Antisense Oligonucleotides in a Model of β-amyloidosis. Neuron. 96 : 1013-1023.e4 View in Article Google Scholar

Iba M.

Guo J.L.

McBride J.D.

Zhang B.

Trojanowski J.Q.

Lee V.M.-Y. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer’s-like tauopathy. J. Neurosci. 33 : 1024-1037 View in Article Google Scholar

Iliff J.J.

Wang M.

Liao Y.

Plogg B.A.

Peng W.

Gundersen G.A.

Benveniste H.

Vates G.E.

Deane R.

Goldman S.A.

et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci. Transl. Med. 4 : 147ra111 View in Article Google Scholar

in t’ Veld B.A.

Ruitenberg A.

Hofman A.

Launer L.J.

van Duijn C.M.

Stijnen T.

Breteler M.M.

Stricker B.H. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N. Engl. J. Med. 345 : 1515-1521 View in Article Google Scholar

Jack Jr., C.R.

Holtzman D.M. Biomarker modeling of Alzheimer’s disease. Neuron. 80 : 1347-1358 View in Article Google Scholar

Jack Jr., C.R.

Bennett D.A.

Blennow K.

Carrillo M.C.

Dunn B.

Haeberlein S.B.

Holtzman D.M.

Jagust W.

Jessen F.

Karlawish J.

et al.

Contributors NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14 : 535-562 View in Article Google Scholar

Jack Jr., C.R.

Wiste H.J.

Schwarz C.G.

Lowe V.J.

Senjem M.L.

Vemuri P.

Weigand S.D.

Therneau T.M.

Knopman D.S.

Gunter J.L.

et al. Longitudinal tau PET in ageing and Alzheimer’s disease. Brain. 141 : 1517-1528 View in Article Google Scholar

Jamieson G.A.

Maitland N.J.

Wilcock G.K.

Craske J.

Itzhaki R.F. Latent herpes simplex virus type 1 in normal and Alzheimer’s disease brains. J. Med. Virol. 33 : 224-227 View in Article Google Scholar

Jamieson G.A.

Maitland N.J.

Wilcock G.K.

Yates C.M.

Itzhaki R.F. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J. Pathol. 167 : 365-368 View in Article Google Scholar

Jaunmuktane Z.

Mead S.

Ellis M.

Wadsworth J.D.F.

Nicoll A.J.

Kenny J.

Launchbury F.

Linehan J.

Richard-Loendt A.

Walker A.S.

et al. Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 525 : 247-250 View in Article Google Scholar

Jiang Q.

Lee C.Y.D.

Mandrekar S.

Wilkinson B.

Cramer P.

Zelcer N.

Mann K.

Lamb B.

Willson T.M.

Collins J.L.

et al. ApoE promotes the proteolytic degradation of Abeta. Neuron. 58 : 681-693 View in Article Google Scholar

Jonsson T.

Atwal J.K.

Steinberg S.

Snaedal J.

Jonsson P.V.

Bjornsson S.

Stefansson H.

Sulem P.

Gudbjartsson D.

Maloney J.

et al. A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature. 488 : 96-99 View in Article Google Scholar

Ju Y.S.

Ooms S.J.

Sutphen C.

Macauley S.L.

Zangrilli M.A.

Jerome G.

Fagan A.M.

Mignot E.

Zempel J.M.

Claassen J.A.H.R.

Holtzman D.M. Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain. 140 : 2104-2111 View in Article Google Scholar

Kamenetz F.

Tomita T.

Hsieh H.

Seabrook G.

Borchelt D.

Iwatsubo T.

Sisodia S.

Malinow R. APP processing and synaptic function. Neuron. 37 : 925-937 View in Article Google Scholar

Kang J.-E.

Lim M.M.

Bateman R.J.

Lee J.J.

Smyth L.P.

Cirrito J.R.

Fujiki N.

Nishino S.

Holtzman D.M. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 326 : 1005-1007 View in Article Google Scholar

Karch C.M.

Goate A.M. Alzheimer’s disease risk genes and mechanisms of disease pathogenesis. Biol. Psychiatry. 77 : 43-51 View in Article Google Scholar

Karran E.

Hardy J. A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease. Ann. Neurol. 76 : 185-205 View in Article Google Scholar

Karran E.

Mercken M.

De Strooper B. The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics. Nat. Rev. Drug Discov. 10 : 698-712 View in Article Google Scholar

Katsimpardi L.

Litterman N.K.

Schein P.A.

Miller C.M.

Loffredo F.S.

Wojtkiewicz G.R.

Chen J.W.

Lee R.T.

Wagers A.J.

Rubin L.L. Vascular and neurogenic rejuvenation of the aging mouse brain by young systemic factors. Science. 344 : 630-634 View in Article Google Scholar

Keren-Shaul H.

Spinrad A.

Weiner A.

Matcovitch-Natan O.

Dvir-Szternfeld R.

Ulland T.K.

David E.

Baruch K.

Lara-Astaiso D.

Toth B.

et al. A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease. Cell. 169 : 1276-1290.e17 View in Article Google Scholar

Kheifets V.

Braithwaite S.P. Plasma-Based Strategies for Therapeutic Modulation of Brain Aging. Neurotherapeutics. 16 : 675-684 View in Article Google Scholar

Kidd M. Paired helical filaments in electron microscopy of Alzheimer’s disease. Nature. 197 : 192-193 View in Article Google Scholar

Kim J.

Jiang H.

Park S.

Eltorai A.E.M.

Stewart F.R.

Yoon H.

Basak J.M.

Finn M.B.

Holtzman D.M. Haploinsufficiency of human APOE reduces amyloid deposition in a mouse model of amyloid-β amyloidosis. J. Neurosci. 31 : 18007-18012 View in Article Google Scholar

Kim J.

Eltorai A.E.M.

Jiang H.

Liao F.

Verghese P.B.

Kim J.

Stewart F.R.

Basak J.M.

Holtzman D.M. Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis. J. Exp. Med. 209 : 2149-2156 View in Article Google Scholar

Kinney J.W.

Bemiller S.M.

Murtishaw A.S.

Leisgang A.M.

Salazar A.M.

Lamb B.T. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement. (N. Y.). 4 : 575-590 View in Article Scopus (171)

Google Scholar

Knoferle J.

Yoon S.Y.

Walker D.

Leung L.

Gillespie A.K.

Tong L.M.

Bien-Ly N.

Huang Y. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice. J. Neurosci. 34 : 14069-14078 View in Article Scopus (30)

Google Scholar

Krasemann S.

Madore C.

Cialic R.

Baufeld C.

Calcagno N.

El Fatimy R.

Beckers L.

O’Loughlin E.

Xu Y.

Fanek Z.

et al. The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases. Immunity. 47 : 566-581.e9 View in Article Google Scholar

Kumar D.K.V.

Choi S.H.

Washicosky K.J.

Eimer W.A.

Tucker S.

Ghofrani J.

Lefkowitz A.

McColl G.

Goldstein L.E.

Tanzi R.E.

Moir R.D. Amyloid-β peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease. Sci. Transl. Med. 8 : 340ra72 View in Article Google Scholar

Kunkle B.W.

Grenier-Boley B.

Sims R.

Bis J.C.

Damotte V.

Naj A.C.

Boland A.

Vronskaya M.

van der Lee S.J.

Amlie-Wolf A.

et al.

Alzheimer Disease Genetics Consortium (ADGC)

European Alzheimer’s Disease Initiative (EADI)

Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE)

Genetic and Environmental Risk in AD/Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease Consortium (GERAD/PERADES) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet. 51 : 414-430 View in Article Scopus (0)

Google Scholar

Lacosta A.-M.

Pascual-Lucas M.

Pesini P.

Casabona D.

Pérez-Grijalba V.

Marcos-Campos I.

Sarasa L.

Canudas J.

Badi H.

Monleón I.

et al. Safety, tolerability and immunogenicity of an active anti-Aβ 40 vaccine (ABvac40) in patients with Alzheimer’s disease: a randomised, double-blind, placebo-controlled, phase I trial. Alzheimers Res. Ther. 10 : 12 View in Article Google Scholar

Laird F.M.

Cai H.

Savonenko A.V.

Farah M.H.

He K.

Melnikova T.

Wen H.

Chiang H.-C.

Xu G.

Koliatsos V.E.

et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J. Neurosci. 25 : 11693-11709 View in Article Google Scholar

Lawlor B.

Segurado R.

Kennelly S.

Olde Rikkert M.G.M.

Howard R.

Pasquier F.

Börjesson-Hanson A.

Tsolaki M.

Lucca U.

Molloy D.W.

et al.

NILVAD Study Group Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Med. 15 : e1002660 View in Article Google Scholar

Lewis J.

Dickson D.W.

Lin W.L.

Chisholm L.

Corral A.

Jones G.

Yen S.H.

Sahara N.

Skipper L.

Yager D.

et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 293 : 1487-1491 View in Article Google Scholar

Leyns C.E.G.

Ulrich J.D.

Finn M.B.

Stewart F.R.

Koscal L.J.

Remolina Serrano J.

Robinson G.O.

Anderson E.

Colonna M.

Holtzman D.M. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy. Proc. Natl. Acad. Sci. USA. 114 : 11524-11529 View in Article Google Scholar

Leyns C.E.G.

Gratuze M.

Narasimhan S.

Jain N.

Koscal L.J.

Jiang H.

Manis M.

Colonna M.

Lee V.M.Y.

Ulrich J.D.

Holtzman D.M. TREM2 function impedes tau seeding in neuritic plaques. Nat. Neurosci. 22 : 1217-1222 View in Article Google Scholar

Liao F.

Hori Y.

Hudry E.

Bauer A.Q.

Jiang H.

Mahan T.E.

Lefton K.B.

Zhang T.J.

Dearborn J.T.

Kim J.

et al. Anti-ApoE antibody given after plaque onset decreases Aβ accumulation and improves brain function in a mouse model of Aβ amyloidosis. J. Neurosci. 34 : 7281-7292 View in Article Google Scholar

Liao F.

Li A.

Xiong M.

Bien-Ly N.

Jiang H.

Zhang Y.

Finn M.B.

Hoyle R.

Keyser J.

Lefton K.B.

et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J. Clin. Invest. 128 : 2144-2155 View in Article Google Scholar

Liddelow S.A.

Guttenplan K.A.

Clarke L.E.

Bennett F.C.

Bohlen C.J.

Schirmer L.

Bennett M.L.

Münch A.E.

Chung W.-S.

Peterson T.C.

et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 541 : 481-487 View in Article Google Scholar

Lippens G.

Gigant B. Elucidating Tau function and dysfunction in the era of cryo-EM. J. Biol. Chem. 294 : 9316-9325 View in Article Google Scholar

Liu L.

Drouet V.

Wu J.W.

Witter M.P.

Small S.A.

Clelland C.

Duff K. Trans-synaptic spread of tau pathology in vivo. PLoS ONE. 7 : e31302 View in Article Google Scholar

Liu C.-C.

Zhao N.

Fu Y.

Wang N.

Linares C.

Tsai C.-W.

Bu G. ApoE4 Accelerates Early Seeding of Amyloid Pathology. Neuron. 96 : 1024-1032.e3 View in Article Google Scholar

Liu L.

Ding L.

Rovere M.

Wolfe M.S.

Selkoe D.J. A cellular complex of BACE1 and γ-secretase sequentially generates Aβ from its full-length precursor. J. Cell Biol. 218 : 644-663 View in Article Google Scholar

Livingston G.

Sommerlad A.

Orgeta V.

Costafreda S.G.

Huntley J.

Ames D.

Ballard C.

Banerjee S.

Burns A.

Cohen-Mansfield J.

et al. Dementia prevention, intervention, and care. Lancet. 390 : 2673-2734 View in Article Google Scholar

Logovinsky V.

Satlin A.

Lai R.

Swanson C.

Kaplow J.

Osswald G.

Basun H.

Lannfelt L. Safety and tolerability of BAN2401--a clinical study in Alzheimer’s disease with a protofibril selective Aβ antibody. Alzheimers Res. Ther. 8 : 14 View in Article Google Scholar

Lopez Lopez C.

Tariot P.N.

Caputo A.

Langbaum J.B.

Liu F.

Riviere M.-E.

Langlois C.

Rouzade-Dominguez M.-L.

Zalesak M.

Hendrix S.

et al. The Alzheimer’s Prevention Initiative Generation Program: Study design of two randomized controlled trials for individuals at risk for clinical onset of Alzheimer’s disease. Alzheimers Dement. (N. Y.). 5 : 216-227 View in Article Google Scholar

Lovestone S.

Boada M.

Dubois B.

Hüll M.

Rinne J.O.

Huppertz H.-J.

Calero M.

Andrés M.V.

Gómez-Carrillo B.

León T.

del Ser T.

ARGO investigators A phase II trial of tideglusib in Alzheimer’s disease. J. Alzheimers Dis. 45 : 75-88 View in Article Google Scholar

Lowe V.J.

Lundt E.S.

Albertson S.M.

Przybelski S.A.

Senjem M.L.

Parisi J.E.

Kantarci K.

Boeve B.

Jones D.T.

Knopman D.

et al. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. Alzheimers Dement. 15 : 927-939 View in Article Google Scholar

Lucey B.P.

Hicks T.J.

McLeland J.S.

Toedebusch C.D.

Boyd J.

Elbert D.L.

Patterson B.W.

Baty J.

Morris J.C.

Ovod V.

et al. Effect of sleep on overnight cerebrospinal fluid amyloid β kinetics. Ann. Neurol. 83 : 197-204 View in Article Google Scholar

Mandelkow E.

von Bergen M.

Biernat J.

Mandelkow E.-M. Structural principles of tau and the paired helical filaments of Alzheimer’s disease. Brain Pathol. 17 : 83-90 View in Article Google Scholar

Marcelli S.

Corbo M.

Iannuzzi F.

Negri L.

Blandini F.

Nistico R.

Feligioni M. The Involvement of Post-Translational Modifications in Alzheimer’s Disease. Curr. Alzheimer Res. 15 : 313-335 View in Article Google Scholar

Martiskainen H.

Herukka S.-K.

Stančáková A.

Paananen J.

Soininen H.

Kuusisto J.

Laakso M.

Hiltunen M. Decreased plasma β-amyloid in the Alzheimer’s disease APP A673T variant carriers. Ann. Neurol. 82 : 128-132 View in Article Google Scholar

Masters C.L.

Selkoe D.J. Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2 : a006262 View in Article Google Scholar

Masters C.L.

Simms G.

Weinman N.A.

Multhaup G.

McDonald B.L.

Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 82 : 4245-4249 View in Article Google Scholar

Matarin M.

Salih D.A.

Yasvoina M.

Cummings D.M.

Guelfi S.

Liu W.

Nahaboo Solim M.A.

Moens T.G.

Paublete R.M.

Ali S.S.

et al. A genome-wide gene-expression analysis and database in transgenic mice during development of amyloid or tau pathology. Cell Rep. 10 : 633-644 View in Article Google Scholar

Mathys H.

Davila-Velderrain J.

Peng Z.

Gao F.

Mohammadi S.

Young J.Z.

Menon M.

He L.

Abdurrob F.

Jiang X.

et al. Single-cell transcriptomic analysis of Alzheimer’s disease. Nature. 570 : 332-337 View in Article Google Scholar

Mattsson N.

Cullen N.C.

Andreasson U.

Zetterberg H.

Blennow K. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA Neurol. 76 : 791-799 View in Article Google Scholar

McKhann G.M.

Knopman D.S.

Chertkow H.

Hyman B.T.

Jack Jr., C.R.

Kawas C.H.

Klunk W.E.

Koroshetz W.J.

Manly J.J.

Mayeux R.

et al. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7 : 263-269 View in Article Google Scholar

McShane R.

Areosa Sastre A.

Minakaran N. Memantine for dementia. Cochrane Database Syst. Rev. : CD003154 View in Article Google Scholar

Meyer P.-F.

Tremblay-Mercier J.

Leoutsakos J.

Madjar C.

Lafaille-Maignan M.-É.

Savard M.

Rosa-Neto P.

Poirier J.

Etienne P.

Breitner J.

PREVENT-AD Research Group INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease. Neurology. 92 : e2070-e2080 View in Article Google Scholar

Middeldorp J.

Lehallier B.

Villeda S.A.

Miedema S.S.M.

Evans E.

Czirr E.

Zhang H.

Luo J.

Stan T.

Mosher K.I.

et al. Preclinical Assessment of Young Blood Plasma for Alzheimer Disease. JAMA Neurol. 73 : 1325-1333 View in Article Google Scholar

Mielke M.M.

Syrjanen J.A.

Blennow K.

Zetterberg H.

Vemuri P.

Skoog I.

Machulda M.M.

Kremers W.K.

Knopman D.S.

Jack Jr., C.

et al. Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. Neurology. 93 : e252-e260 View in Article Google Scholar

Min S.-W.

Cho S.-H.

Zhou Y.

Schroeder S.

Haroutunian V.

Seeley W.W.

Huang E.J.

Shen Y.

Masliah E.

Mukherjee C.

et al. Acetylation of tau inhibits its degradation and contributes to tauopathy. Neuron. 67 : 953-966 View in Article Google Scholar

Minter M.R.

Zhang C.

Leone V.

Ringus D.L.

Zhang X.

Oyler-Castrillo P.

Musch M.W.

Liao F.

Ward J.F.

Holtzman D.M.

et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Sci. Rep. 6 : 30028 View in Article Google Scholar

Mishra S.

Blazey T.M.

Holtzman D.M.

Cruchaga C.

Su Y.

Morris J.C.

Benzinger T.L.S.

Gordon B.A. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype. Brain. 141 : 1828-1839 View in Article Google Scholar

Moir R.D.

Lathe R.

Tanzi R.E. The antimicrobial protection hypothesis of Alzheimer’s disease. Alzheimers Dement. 14 : 1602-1614 View in Article Google Scholar

Morris J.C. Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int. Psychogeriatr. 9 : 173-176, discussion 177–178 View in Article Google Scholar

Morris J.C. Editorial: Is Now the Time for Combination Therapies for Alzheimer Disease?. J. Prev. Alzheimers Dis. 6 : 153-154 View in Article Google Scholar

Morris J.C.

Roe C.M.

Grant E.A.

Head D.

Storandt M.

Goate A.M.

Fagan A.M.

Holtzman D.M.

Mintun M.A. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Arch. Neurol. 66 : 1469-1475 View in Article Google Scholar

Morris J.C.

Roe C.M.

Xiong C.

Fagan A.M.

Goate A.M.

Holtzman D.M.

Mintun M.A. APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging. Ann. Neurol. 67 : 122-131 View in Article Google Scholar

Musiek E.S.

Holtzman D.M. Three dimensions of the amyloid hypothesis: time, space and ‘wingmen’. Nat. Neurosci. 18 : 800-806 View in Article Google Scholar

Najm R.

Jones E.A.

Huang Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease. Mol. Neurodegener. 14 : 24 View in Article Google Scholar

Nakamura A.

Kaneko N.

Villemagne V.L.

Kato T.

Doecke J.

Doré V.

Fowler C.

Li Q.-X.

Martins R.

Rowe C.

et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature. 554 : 249-254 View in Article Google Scholar

Namba Y.

Tomonaga M.

Kawasaki H.

Otomo E.

Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer’s disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res. 541 : 163-166 View in Article Google Scholar

Nathan B.P.

Bellosta S.

Sanan D.A.

Weisgraber K.H.

Mahley R.W.

Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264 : 850-852 View in Article Google Scholar

Nelson P.T.

Alafuzoff I.

Bigio E.H.

Bouras C.

Braak H.

Cairns N.J.

Castellani R.J.

Crain B.J.

Davies P.

Del Tredici K.

et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 71 : 362-381 View in Article Google Scholar

Nicoll J.A.R.

Buckland G.R.

Harrison C.H.

Page A.

Harris S.

Love S.

Neal J.W.

Holmes C.

Boche D. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer’s disease. Brain. : 2113-2126 View in Article Google Scholar

Nortley R.

Korte N.

Izquierdo P.

Hirunpattarasilp C.

Mishra A.

Jaunmuktane Z.

Kyrargyri V.

Pfeiffer T.

Khennouf L.

Madry C.

et al. Amyloid β oligomers constrict human capillaries in Alzheimer’s disease via signaling to pericytes. Science. 365 : eaav9518 View in Article Google Scholar

Novak P.

Zilka N.

Zilkova M.

Kovacech B.

Skrabana R.

Ondrus M.

Fialova L.

Kontsekova E.

Otto M.

Novak M. AADvac1, an Active Immunotherapy for Alzheimer’s Disease and Non Alzheimer Tauopathies: An Overview of Preclinical and Clinical Development. J. Prev. Alzheimers Dis. 6 : 63-69 View in Article Google Scholar

Nuriel T.

Angulo S.L.

Khan U.

Ashok A.

Chen Q.

Figueroa H.Y.

Emrani S.

Liu L.

Herman M.

Barrett G.

et al. Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology. Nat. Commun. 8 : 1464 View in Article Google Scholar

Okochi M.

Tagami S.

Yanagida K.

Takami M.

Kodama T.S.

Mori K.

Nakayama T.

Ihara Y.

Takeda M. γ-secretase modulators and presenilin 1 mutants act differently on presenilin/γ-secretase function to cleave Aβ42 and Aβ43. Cell Rep. 3 : 42-51 View in Article Google Scholar

Olsson M.

Ärlig J.

Hedner J.

Blennow K.

Zetterberg H. Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer’s disease. Sleep (Basel). 41 https://doi.org/10.1093/sleep/zsy025 View in Article Google Scholar

Ooms S.

Overeem S.

Besse K.

Rikkert M.O.

Verbeek M.

Claassen J.A.H.R. Effect of 1 night of total sleep deprivation on cerebrospinal fluid β-amyloid 42 in healthy middle-aged men: a randomized clinical trial. JAMA Neurol. 71 : 971-977 View in Article Google Scholar

Ossenkoppele R.

Pijnenburg Y.A.L.

Perry D.C.

Cohn-Sheehy B.I.

Scheltens N.M.E.

Vogel J.W.

Kramer J.H.

van der Vlies A.E.

La Joie R.

Rosen H.J.

et al. The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain. 138 : 2732-2749 View in Article Google Scholar

Ostrowitzki S.

Lasser R.A.

Dorflinger E.

Scheltens P.

Barkhof F.

Nikolcheva T.

Ashford E.

Retout S.

Hofmann C.

Delmar P.

et al.

SCarlet RoAD Investigators A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease. Alzheimers Res. Ther. 9 : 95 View in Article Google Scholar

Ou-Yang M.-H.

Kurz J.E.

Nomura T.

Popovic J.

Rajapaksha T.W.

Dong H.

Contractor A.

Chetkovich D.M.

Tourtellotte W.G.

Vassar R. Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice. Sci. Transl. Med. 10 : eaao5620 View in Article Google Scholar

Ovod V.

Ramsey K.N.

Mawuenyega K.G.

Bollinger J.G.

Hicks T.

Schneider T.

Sullivan M.

Paumier K.

Holtzman D.M.

Morris J.C.

et al. Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. Alzheimers Dement. 13 : 841-849 View in Article Google Scholar

Palmqvist S.

Janelidze S.

Stomrud E.

Zetterberg H.

Karl J.

Zink K.

Bittner T.

Mattsson N.

Eichenlaub U.

Blennow K.

Hansson O. Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status. JAMA Neurol. ( ) https://doi.org/10.1001/jamaneurol.2019.1632 View in Article Google Scholar

Panza F.

Lozupone M.

Solfrizzi V.

Sardone R.

Piccininni C.

Dibello V.

Stallone R.

Giannelli G.

Bellomo A.

Greco A.

et al. BACE inhibitors in clinical development for the treatment of Alzheimer’s disease. Expert Rev. Neurother. 18 : 847-857 View in Article Google Scholar

Parhizkar S.

Arzberger T.

Brendel M.

Kleinberger G.

Deussing M.

Focke C.

Nuscher B.

Xiong M.

Ghasemigharagoz A.

Katzmarski N.

et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nat. Neurosci. 22 : 191-204 View in Article Google Scholar

Pascoal T.A.

Mathotaarachchi S.

Kang M.S.

Mohaddes S.

Shin M.

Park A.Y.

Parent M.J.

Benedet A.L.

Chamoun M.

Therriault J.

et al. Aβ-induced vulnerability propagates via the brain’s default mode network. Nat. Commun. 10 : 2353 View in Article Google Scholar

Peters F.

Salihoglu H.

Rodrigues E.

Herzog E.

Blume T.

Filser S.

Dorostkar M.

Shimshek D.R.

Brose N.

Neumann U.

Herms J. BACE1 inhibition more effectively suppresses initiation than progression of β-amyloid pathology. Acta Neuropathol. 135 : 695-710 View in Article Google Scholar

Pontecorvo M.J.

Devous M.D.

Kennedy I.

Navitsky M.

Lu M.

Galante N.

Salloway S.

Doraiswamy P.M.

Southekal S.

Arora A.K.

et al. A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer’s disease dementia. Brain. 142 : 1723-1735 View in Article Google Scholar

Pooler A.M.

Polydoro M.

Maury E.A.

Nicholls S.B.

Reddy S.M.

Wegmann S.

William C.

Saqran L.

Cagsal-Getkin O.

Pitstick R.

et al. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer’s disease. Acta Neuropathol. Commun. 3 : 14 View in Article Google Scholar

Preische O.

Schultz S.A.

Apel A.

Kuhle J.

Kaeser S.A.

Barro C.

Gräber S.

Kuder-Buletta E.

LaFougere C.

Laske C.

et al.

Dominantly Inherited Alzheimer Network Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease. Nat. Med. 25 : 277-283 View in Article Google Scholar

Price J.L.

Morris J.C. Tangles and plaques in nondemented aging and “preclinical” Alzheimer’s disease. Ann. Neurol. 45 : 358-368 View in Article Google Scholar

Price J.L.

McKeel Jr., D.W.

Buckles V.D.

Roe C.M.

Xiong C.

Grundman M.

Hansen L.A.

Petersen R.C.

Parisi J.E.

Dickson D.W.

et al. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging. 30 : 1026-1036 View in Article Google Scholar

Purro S.A.

Farrow M.A.

Linehan J.

Nazari T.

Thomas D.X.

Chen Z.

Mengel D.

Saito T.

Saido T.

Rudge P.

et al. Transmission of amyloid-β protein pathology from cadaveric pituitary growth hormone. Nature. 564 : 415-419 View in Article Google Scholar

Qi Y.

Klyubin I.

Cuello A.C.

Rowan M.J. NLRP3-dependent synaptic plasticity deficit in an Alzheimer’s disease amyloidosis model in vivo. Neurobiol. Dis. 114 : 24-30 View in Article Google Scholar

Rajapaksha T.W.

Eimer W.A.

Bozza T.C.

Vassar R. The Alzheimer’s β-secretase enzyme BACE1 is required for accurate axon guidance of olfactory sensory neurons and normal glomerulus formation in the olfactory bulb. Mol. Neurodegener. 6 : 88 View in Article Google Scholar

Readhead B.

Haure-Mirande J.-V.

Funk C.C.

Richards M.A.

Shannon P.

Haroutunian V.

Sano M.

Liang W.S.

Beckmann N.D.

Price N.D.

et al. Multiscale Analysis of Independent Alzheimer’s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 99 : 64-82.e7 View in Article Google Scholar

Reiman E.M.

Langbaum J.B.S.

Fleisher A.S.

Caselli R.J.

Chen K.

Ayutyanont N.

Quiroz Y.T.

Kosik K.S.

Lopera F.

Tariot P.N. Alzheimer’s Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J. Alzheimers Dis. 26 : 321-329 View in Article Google Scholar

Relkin N.R.

Thomas R.G.

Rissman R.A.

Brewer J.B.

Rafii M.S.

van Dyck C.H.

Jack C.R.

Sano M.

Knopman D.S.

Raman R.

et al.

Alzheimer’s Disease Cooperative Study A phase 3 trial of IV immunoglobulin for Alzheimer disease. Neurology. 88 : 1768-1775 View in Article Google Scholar

Risacher S.L.

Kim S.

Nho K.

Foroud T.

Shen L.

Petersen R.C.

Jack Jr., C.R.

Beckett L.A.

Aisen P.S.

Koeppe R.A.

et al.

Alzheimer’s Disease Neuroimaging Initiative (ADNI) APOE effect on Alzheimer’s disease biomarkers in older adults with significant memory concern. Alzheimers Dement. 11 : 1417-1429 View in Article Google Scholar

Roh J.H.

Huang Y.

Bero A.W.

Kasten T.

Stewart F.R.

Bateman R.J.

Holtzman D.M. Disruption of the sleep-wake cycle and diurnal fluctuation of β-amyloid in mice with Alzheimer’s disease pathology. Sci. Transl. Med. 4 : 150ra122 View in Article Google Scholar

Rosenberg J.B.

Kaplitt M.G.

De B.P.

Chen A.

Flagiello T.

Salami C.

Pey E.

Zhao L.

Ricart Arbona R.J.

Monette S.

et al. AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer’s Disease. Hum. Gene Ther. Clin. Dev. 29 : 24-47 View in Article Google Scholar

Roses A.D. Apolipoprotein E alleles as risk factors in Alzheimer’s disease. Annu. Rev. Med. 47 : 387-400 View in Article Google Scholar

Ryan P.

Xu M.

Davey A.K.

Danon J.J.

Mellick G.D.

Kassiou M.

Rudrawar S. O-GlcNAc Modification Protects against Protein Misfolding and Aggregation in Neurodegenerative Disease. ACS Chem. Neurosci. 10 : 2209-2221 View in Article Google Scholar

Saji N.

Niida S.

Murotani K.

Hisada T.

Tsuduki T.

Sugimoto T.

Kimura A.

Toba K.

Sakurai T. Analysis of the relationship between the gut microbiome and dementia: a cross-sectional study conducted in Japan. Sci. Rep. 9 : 1008 View in Article Google Scholar

Salloway S.

Sperling R.

Fox N.C.

Blennow K.

Klunk W.

Raskind M.

Sabbagh M.

Honig L.S.

Porsteinsson A.P.

Ferris S.

et al.

Bapineuzumab 301 and 302 Clinical Trial Investigators Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N. Engl. J. Med. 370 : 322-333 View in Article Google Scholar

Sanders D.W.

Kaufman S.K.

DeVos S.L.

Sharma A.M.

Mirbaha H.

Li A.

Barker S.J.

Foley A.C.

Thorpe J.R.

Serpell L.C.

et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 82 : 1271-1288 View in Article Google Scholar

Sano M.

Bell K.L.

Galasko D.

Galvin J.E.

Thomas R.G.

van Dyck C.H.

Aisen P.S. A randomized, double-blind, placebo-controlled trial of simvastatin to treat Alzheimer disease. Neurology. 77 : 556-563 View in Article Google Scholar

Sato C.

Barthélemy N.R.

Mawuenyega K.G.

Patterson B.W.

Gordon B.A.

Jockel-Balsarotti J.

Sullivan M.

Crisp M.J.

Kasten T.

Kirmess K.M.

et al. Tau Kinetics in Neurons and the Human Central Nervous System. Neuron. 97 : 1284-1298.e7 View in Article Google Scholar

Sayed F.A.

Telpoukhovskaia M.

Kodama L.

Li Y.

Zhou Y.

Le D.

Hauduc A.

Ludwig C.

Gao F.

Clelland C.

et al. Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy. Proc. Natl. Acad. Sci. USA. 115 : 10172-10177 View in Article Google Scholar

Schenk D.

Barbour R.

Dunn W.

Gordon G.

Grajeda H.

Guido T.

Hu K.

Huang J.

Johnson-Wood K.

Khan K.

et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400 : 173-177 View in Article Google Scholar

Schultz S.A.

Gordon B.A.

Mishra S.

Su Y.

Perrin R.J.

Cairns N.J.

Morris J.C.

Ances B.M.

Benzinger T.L.S. Widespread distribution of tauopathy in preclinical Alzheimer’s disease. Neurobiol. Aging. 72 : 177-185 View in Article Google Scholar

Selkoe D.J. Alzheimer disease and aducanumab: adjusting our approach. Nat. Rev. Neurol. 15 : 365-366 View in Article Google Scholar

Selkoe D.J.

Hardy J. The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol. Med. 8 : 595-608 View in Article Google Scholar

Serenó L.

Coma M.

Rodríguez M.

Sánchez-Ferrer P.

Sánchez M.B.

Gich I.

Agulló J.M.

Pérez M.

Avila J.

Guardia-Laguarta C.

et al. A novel GSK-3beta inhibitor reduces Alzheimer’s pathology and rescues neuronal loss in vivo. Neurobiol. Dis. 35 : 359-367 View in Article Google Scholar

Sevigny J.

Chiao P.

Bussière T.

Weinreb P.H.

Williams L.

Maier M.

Dunstan R.

Salloway S.

Chen T.

Ling Y.

et al. The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease. Nature. 537 : 50-56 View in Article Google Scholar

Sha S.J.

Deutsch G.K.

Tian L.

Richardson K.

Coburn M.

Gaudioso J.L.

Marcal T.

Solomon E.

Boumis A.

Bet A.

et al. Safety, Tolerability, and Feasibility of Young Plasma Infusion in the Plasma for Alzheimer Symptom Amelioration Study: A Randomized Clinical Trial. JAMA Neurol. 76 : 35-40 View in Article Google Scholar

Shankar G.M.

Bloodgood B.L.

Townsend M.

Walsh D.M.

Selkoe D.J.

Sabatini B.L. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27 : 2866-2875 View in Article Google Scholar

Shankar G.M.

Li S.

Mehta T.H.

Garcia-Munoz A.

Shepardson N.E.

Smith I.

Brett F.M.

Farrell M.A.

Rowan M.J.

Lemere C.A.

et al. Amyloid-beta protein dimers isolated directly from Alzheimer’s brains impair synaptic plasticity and memory. Nat. Med. 14 : 837-842 View in Article Google Scholar

Shi Y.

Holtzman D.M. Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight. Nat. Rev. Immunol. 18 : 759-772 View in Article Google Scholar

Shi Y.

Yamada K.

Liddelow S.A.

Smith S.T.

Zhao L.

Luo W.

Tsai R.M.

Spina S.

Grinberg L.T.

Rojas J.C.

et al.

Alzheimer’s Disease Neuroimaging Initiative ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature. 549 : 523-527 View in Article Google Scholar

Sohn P.D.

Tracy T.E.

Son H.-I.

Zhou Y.

Leite R.E.P.

Miller B.L.

Seeley W.W.

Grinberg L.T.

Gan L. Acetylated tau destabilizes the cytoskeleton in the axon initial segment and is mislocalized to the somatodendritic compartment. Mol. Neurodegener. 11 : 47 View in Article Google Scholar

Song W.M.

Joshita S.

Zhou Y.

Ulland T.K.

Gilfillan S.

Colonna M. Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism. J. Exp. Med. 215 : 745-760 View in Article Google Scholar

Soscia S.J.

Kirby J.E.

Washicosky K.J.

Tucker S.M.

Ingelsson M.

Hyman B.

Burton M.A.

Goldstein L.E.

Duong S.

Tanzi R.E.

Moir R.D. The Alzheimer’s disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS ONE. 5 : e9505 View in Article Google Scholar

Sosna J.

Philipp S.

Albay 3rd, R.

Reyes-Ruiz J.M.

Baglietto-Vargas D.

LaFerla F.M.

Glabe C.G. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer’s disease. Mol. Neurodegener. 13 : 11 View in Article Google Scholar

Spangenberg E.

Severson P.L.

Hohsfield L.A.

Crapser J.

Zhang J.

Burton E.A.

Zhang Y.

Spevak W.

Lin J.

Phan N.Y.

et al. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer’s disease model. Nat. Commun. 10 : 3758 View in Article Google Scholar

Sperling R.A.

Rentz D.M.

Johnson K.A.

Karlawish J.

Donohue M.

Salmon D.P.

Aisen P. The A4 study: stopping AD before symptoms begin?. Sci. Transl. Med. 6 : 228fs13 View in Article Google Scholar

Spitzer P.

Condic M.

Herrmann M.

Oberstein T.J.

Scharin-Mehlmann M.

Gilbert D.F.

Friedrich O.

Grömer T.

Kornhuber J.

Lang R.

Maler J.M. Amyloidogenic amyloid-β-peptide variants induce microbial agglutination and exert antimicrobial activity. Sci. Rep. 6 : 32228 View in Article Google Scholar

Stephenson D.

Perry D.

Bens C.

Bain L.J.

Berry D.

Krams M.

Sperling R.

Dilts D.

Luthman J.

Hanna D.

et al. Charting a path toward combination therapy for Alzheimer’s disease. Expert Rev. Neurother. 15 : 107-113 View in Article Google Scholar

Strittmatter W.J.

Saunders A.M.

Schmechel D.

Pericak-Vance M.

Enghild J.

Salvesen G.S.

Roses A.D. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90 : 1977-1981 View in Article Google Scholar

Strittmatter W.J.

Saunders A.M.

Goedert M.

Weisgraber K.H.

Dong L.M.

Jakes R.

Huang D.Y.

Pericak-Vance M.

Schmechel D.

Roses A.D. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc. Natl. Acad. Sci. USA. 91 : 11183-11186 View in Article Google Scholar

Sun X.

He G.

Qing H.

Zhou W.

Dobie F.

Cai F.

Staufenbiel M.

Huang L.E.

Song W. Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. USA. 103 : 18727-18732 View in Article Google Scholar

Tabrizi S.J.

Leavitt B.R.

Landwehrmeyer G.B.

Wild E.J.

Saft C.

Barker R.A.

Blair N.F.

Craufurd D.

Priller J.

Rickards H.

et al.

Phase 1–2a IONIS-HTTRx Study Site Teams Targeting Huntingtin Expression in Patients with Huntington’s Disease. N. Engl. J. Med. 380 : 2307-2316 View in Article Google Scholar

Tang-Wai D.F.

Graff-Radford N.R.

Boeve B.F.

Dickson D.W.

Parisi J.E.

Crook R.

Caselli R.J.

Knopman D.S.

Petersen R.C. Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology. 63 : 1168-1174 View in Article Google Scholar

Tariot P.N.

Lopera F.

Langbaum J.B.

Thomas R.G.

Hendrix S.

Schneider L.S.

Rios-Romenets S.

Giraldo M.

Acosta N.

Tobon C.

et al.

Alzheimer’s Prevention Initiative The Alzheimer’s Prevention Initiative Autosomal-Dominant Alzheimer’s Disease Trial: A study of crenezumab versus placebo in preclinical PSEN1 E280A mutation carriers to evaluate efficacy and safety in the treatment of autosomal-dominant Alzheimer’s disease, including a placebo-treated noncarrier cohort. Alzheimers Dement. (N. Y.). 4 : 150-160 View in Article Google Scholar

Tcw J.

Goate A.M. Genetics of β-Amyloid Precursor Protein in Alzheimer’s Disease. Cold Spring Harb. Perspect. Med. 7 : a024539 View in Article Google Scholar

Thal L.J.

Ferris S.H.

Kirby L.

Block G.A.

Lines C.R.

Yuen E.

Assaid C.

Nessly M.L.

Norman B.A.

Baranak C.C.

Reines S.A.

Rofecoxib Protocol 078 study group A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology. 30 : 1204-1215 View in Article Google Scholar

Tzeng N.-S.

Chung C.-H.

Lin F.-H.

Chiang C.-P.

Yeh C.-B.

Huang S.-Y.

Lu R.-B.

Chang H.-A.

Kao Y.-C.

Yeh H.-W.

et al. Anti-herpetic Medications and Reduced Risk of Dementia in Patients with Herpes Simplex Virus Infections-a Nationwide, Population-Based Cohort Study in Taiwan. Neurotherapeutics. 15 : 417-429 View in Article Google Scholar

Ulrich J.D.

Finn M.B.

Wang Y.

Shen A.

Mahan T.E.

Jiang H.

Stewart F.R.

Piccio L.

Colonna M.

Holtzman D.M. Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2. Mol. Neurodegener. 9 : 20 View in Article Google Scholar

Ulrich J.D.

Ulland T.K.

Mahan T.E.

Nyström S.

Nilsson K.P.

Song W.M.

Zhou Y.

Reinartz M.

Choi S.

Jiang H.

et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215 : 1047-1058 View in Article Google Scholar

van der Lee S.J.

Conway O.J.

Jansen I.

Carrasquillo M.M.

Kleineidam L.

van den Akker E.

Hernández I.

van Eijk K.R.

Stringa N.

Chen J.A.

et al.

DESGESCO (Dementia Genetics Spanish Consortium), EADB (Alzheimer Disease European DNA biobank)

EADB (Alzheimer Disease European DNA biobank)

IFGC (International FTD-Genomics Consortium), IPDGC (The International Parkinson Disease Genomics Consortium)

IPDGC (The International Parkinson Disease Genomics Consortium)

RiMod-FTD (Risk and Modifying factors in Fronto-Temporal Dementia)

Netherlands Brain Bank (NBB)

GIFT (Genetic Investigation in Frontotemporal Dementia and Alzheimer’s Disease) Study Group A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity. Acta Neuropathol. 138 : 237-250 View in Article Google Scholar

van Hummel A.

Bi M.

Ippati S.

van der Hoven J.

Volkerling A.

Lee W.S.

Tan D.C.S.

Bongers A.

Ittner A.

Ke Y.D.

Ittner L.M. No Overt Deficits in Aged Tau-Deficient C57Bl/6.Mapttm1(EGFP)Kit GFP Knockin Mice. PLoS ONE. 11 : e0163236 View in Article Google Scholar

Vandenberghe R.

Riviere M.-E.

Caputo A.

Sovago J.

Maguire R.P.

Farlow M.

Marotta G.

Sanchez-Valle R.

Scheltens P.

Ryan J.M.

Graf A. Active Aβ immunotherapy CAD106 in Alzheimer’s disease: A phase 2b study. Alzheimers Dement. (N. Y.). 3 : 10-22 View in Article Google Scholar

Varga A.W.

Wohlleber M.E.

Giménez S.

Romero S.

Alonso J.F.

Ducca E.L.

Kam K.

Lewis C.

Tanzi E.B.

Tweardy S.

et al. Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid Aβ42 Levels in Cognitively Normal Elderly. Sleep (Basel). 39 : 2041-2048 View in Article Google Scholar

Vassar R.

Bennett B.D.

Babu-Khan S.

Kahn S.

Mendiaz E.A.

Denis P.

Teplow D.B.

Ross S.

Amarante P.

Loeloff R.

et al. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 286 : 735-741 View in Article Google Scholar

Vellas B.

Black R.

Thal L.J.

Fox N.C.

Daniels M.

McLennan G.

Tompkins C.

Leibman C.

Pomfret M.

Grundman M.

et al. Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders. Curr. Alzheimer Res. 6 : 144-151 View in Article Google Scholar

Venegas C.

Kumar S.

Franklin B.S.

Dierkes T.

Brinkschulte R.

Tejera D.

Vieira-Saecker A.

Schwartz S.

Santarelli F.

Kummer M.P.

et al. Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature. 552 : 355-361 View in Article Google Scholar

Verges D.K.

Restivo J.L.

Goebel W.D.

Holtzman D.M.

Cirrito J.R. Opposing synaptic regulation of amyloid-β metabolism by NMDA receptors in vivo. J. Neurosci. 31 : 11328-11337 View in Article Google Scholar

Verghese P.B.

Castellano J.M.

Garai K.

Wang Y.

Jiang H.

Shah A.

Bu G.

Frieden C.

Holtzman D.M. ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc. Natl. Acad. Sci. USA. 110 : E1807-E1816 View in Article Google Scholar

Vermunt L.

Sikkes S.A.M.

van den Hout A.

Handels R.

Bos I.

van der Flier W.M.

Kern S.

Ousset P.-J.

Maruff P.

Skoog I.

et al. Duration of preclinical, prodromal, and dementia stages of Alzheimer’s disease in relation to age, sex, and APOE genotype. Alzheimers Dement. 15 : 888-898 View in Article Google Scholar

Villeda S.A.

Plambeck K.E.

Middeldorp J.

Castellano J.M.

Mosher K.I.

Luo J.

Smith L.K.

Bieri G.

Lin K.

Berdnik D.

et al. Young blood reverses age-related impairments in cognitive function and synaptic plasticity in mice. Nat. Med. 20 : 659-663 View in Article Google Scholar

Vlad S.C.

Miller D.R.

Kowall N.W.

Felson D.T. Protective effects of NSAIDs on the development of Alzheimer disease. Neurology. 70 : 1672-1677 View in Article Google Scholar

Vogt N.M.

Kerby R.L.

Dill-McFarland K.A.

Harding S.J.

Merluzzi A.P.

Johnson S.C.

Carlsson C.M.

Asthana S.

Zetterberg H.

Blennow K.

et al. Gut microbiome alterations in Alzheimer’s disease. Sci. Rep. 7 : 13537 View in Article Google Scholar

Vos S.J.

Xiong C.

Visser P.J.

Jasielec M.S.

Hassenstab J.

Grant E.A.

Cairns N.J.

Morris J.C.

Holtzman D.M.

Fagan A.M. Preclinical Alzheimer’s disease and its outcome: a longitudinal cohort study. Lancet Neurol. 12 : 957-965 View in Article Google Scholar

Voytyuk I.

De Strooper B.

Chávez-Gutiérrez L. Modulation of γ- and β-Secretases as Early Prevention Against Alzheimer’s Disease. Biol. Psychiatry. 83 : 320-327 View in Article Google Scholar

Wagner S.L.

Rynearson K.D.

Duddy S.K.

Zhang C.

Nguyen P.D.

Becker A.

Vo U.

Masliah D.

Monte L.

Klee J.B.

et al. Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606. J. Pharmacol. Exp. Ther. 362 : 31-44 View in Article Google Scholar

Walker L.C.

Jucker M. Neurodegenerative diseases: expanding the prion concept. Annu. Rev. Neurosci. 38 : 87-103 View in Article Google Scholar

Wang C.

Najm R.

Xu Q.

Jeong D.-E.

Walker D.

Balestra M.E.

Yoon S.Y.

Yuan H.

Li G.

Miller Z.A.

et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24 : 647-657 View in Article Google Scholar

Wang L.

Benzinger T.L.

Su Y.

Christensen J.

Friedrichsen K.

Aldea P.

McConathy J.

Cairns N.J.

Fagan A.M.

Morris J.C.

et al. Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between β-Amyloid and Tauopathy. JAMA Neurol. 73 : 1070-1077 View in Article Google Scholar

Weggen S.

Eriksen J.L.

Das P.

Sagi S.A.

Wang R.

Pietrzik C.U.

Findlay K.A.

Smith T.E.

Murphy M.P.

Bulter T.

et al. A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature. 414 : 212-216 View in Article Google Scholar

Wei W.

Nguyen L.N.

Kessels H.W.

Hagiwara H.

Sisodia S.

Malinow R. Amyloid beta from axons and dendrites reduces local spine number and plasticity. Nat. Neurosci. 13 : 190-196 View in Article Google Scholar

Weingarten M.D.

Lockwood A.H.

Hwo S.Y.

Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA. 72 : 1858-1862 View in Article Google Scholar

West T.

Hu Y.

Verghese P.B.

Bateman R.J.

Braunstein J.B.

Fogelman I.

Budur K.

Florian H.

Mendonca N.

Holtzman D.M. Preclinical and Clinical Development of ABBV-8E12, a Humanized Anti-Tau Antibody, for Treatment of Alzheimer’s Disease and Other Tauopathies. J. Prev. Alzheimers Dis. 4 : 236-241 View in Article Google Scholar

Willem M.

Garratt A.N.

Novak B.

Citron M.

Kaufmann S.

Rittger A.

DeStrooper B.

Saftig P.

Birchmeier C.

Haass C. Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 314 : 664-666 View in Article Google Scholar

Wischik C.M.

Edwards P.C.

Lai R.Y.

Roth M.

Harrington C.R. Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc. Natl. Acad. Sci. USA. 93 : 11213-11218 View in Article Google Scholar

Wozniak M.A.

Mee A.P.

Itzhaki R.F. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J. Pathol. 217 : 131-138 View in Article Google Scholar

Xia W. γ-Secretase and its modulators: Twenty years and beyond. Neurosci. Lett. 701 : 162-169 View in Article Google Scholar

Xie L.

Kang H.

Xu Q.

Chen M.J.

Liao Y.

Thiyagarajan M.

O’Donnell J.

Christensen D.J.

Nicholson C.

Iliff J.J.

et al. Sleep drives metabolite clearance from the adult brain. Science. 342 : 373-377 View in Article Google Scholar

Yaffe K.

Laffan A.M.

Harrison S.L.

Redline S.

Spira A.P.

Ensrud K.E.

Ancoli-Israel S.

Stone K.L. Sleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older women. JAMA. 306 : 613-619 View in Article Google Scholar

Yamada K.

Holth J.K.

Liao F.

Stewart F.R.

Mahan T.E.

Jiang H.

Cirrito J.R.

Patel T.K.

Hochgräfe K.

Mandelkow E.-M.

et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. 211 : 387-393 View in Article Google Scholar

Yanamandra K.

Kfoury N.

Jiang H.

Mahan T.E.

Ma S.

Maloney S.E.

Wozniak D.F.

Diamond M.I.

Holtzman D.M. Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron. 80 : 402-414 View in Article Google Scholar

Yanamandra K.

Jiang H.

Mahan T.E.

Maloney S.E.

Wozniak D.F.

Diamond M.I.

Holtzman D.M. Anti-tau antibody reduces insoluble tau and decreases brain atrophy. Ann. Clin. Transl. Neurol. 2 : 278-288 View in Article Google Scholar

Yanamandra K.

Patel T.K.

Jiang H.

Schindler S.

Ulrich J.D.

Boxer A.L.

Miller B.L.

Kerwin D.R.

Gallardo G.

Stewart F.

et al. Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy. Sci. Transl. Med. 9 : eaal2029 View in Article Google Scholar

Yang G.

Zhou R.

Zhou Q.

Guo X.

Yan C.

Ke M.

Lei J.

Shi Y. Structural basis of Notch recognition by human γ-secretase. Nature. 565 : 192-197 View in Article Google Scholar

Ye L.

Fritschi S.K.

Schelle J.

Obermüller U.

Degenhardt K.

Kaeser S.A.

Eisele Y.S.

Walker L.C.

Baumann F.

Staufenbiel M.

et al. Persistence of Aβ seeds in APP null mouse brain. Nat. Neurosci. 18 : 1559-1561 View in Article Google Scholar

Zhang B.

Gaiteri C.

Bodea L.-G.

Wang Z.

McElwee J.

Podtelezhnikov A.A.

Zhang C.

Xie T.

Tran L.

Dobrin R.

et al. Integrated systems approach identifies genetic nodes and networks in late-onset Alzheimer’s disease. Cell. 153 : 707-720 View in Article Google Scholar

Zhao N.

Liu C.-C.

Van Ingelgom A.J.

Linares C.

Kurti A.

Knight J.A.

Heckman M.G.

Diehl N.N.

Shinohara M.

Martens Y.A.

et al. APOE ε2 is associated with increased tau pathology in primary tauopathy. Nat. Commun. 9 : 4388 View in Article Google Scholar

Zhou R.

Yang G.

Guo X.

Zhou Q.

Lei J.

Shi Y. Recognition of the amyloid precursor protein by human γ-secretase. Science. 363 : eaaw0930 View in Article Google Scholar